DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...
LONDON and CARLSBAD, Calif., Nov. 5, 2025 /PRNewswire/ -- DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today ...
The NGS-based microbiology market is experiencing strong growth, driven by the rising demand for advanced microbial identification, antimicrobial resistance surveillance, and outbreak tracing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback